CORXEL - Latest News and Information
  • All Technology
  • AI
  • Autonomy
  • B2B Growth
  • Big Data
  • BioTech
  • ClimateTech
  • Consumer Tech
  • Crypto
  • Cybersecurity
  • DevOps
  • Digital Marketing
  • Ecommerce
  • EdTech
  • Enterprise
  • FinTech
  • GovTech
  • Hardware
  • HealthTech
  • HRTech
  • LegalTech
  • Nanotech
  • PropTech
  • Quantum
  • Robotics
  • SaaS
  • SpaceTech
AllNewsDealsSocialBlogsVideosPodcastsDigests

Technology Pulse

EMAIL DIGESTS

Daily

Every morning

Weekly

Sunday recap

NewsDealsSocialBlogsVideosPodcasts
HomeCORXEL
CORXEL logo

CORXEL

0 followers

About CORXEL

CORXEL is a clinical-stage biopharmaceutical company focused on developing innovative therapies for cardiometabolic conditions worldwide. The company emphasizes a global approach to treating cardiovascular and metabolic diseases, with programs targeting obesity, type 2 diabetes mellitus, hypertension, and related conditions. CORXEL highlights its world-class team and strategic partnerships to advance its pipeline and bring breakthrough treatments to patients globally.

Recent News

Recent Deals

Key Team Members

Yuval Cohen, Ph.D.

Chief Executive Officer and Director

Sean Moran, CPA, MBA

Chief Financial Officer

Dr. Dominic Smethurst, MA MRCP

Chief Medical Officer

Ian Hodgson, BSc (Hons), Ph. D.

Chief Operating Officer

Christina Bertsch, M.A.

VP of Human Resources

Key Facts

HQ Location

Berkeley Heights, United States

Founded

2019

Employees

11 - 50

Status

Private

Website

https://corxelbio.com